A drug that outperforms placebo in helping people to lose weight is one of a growing number of next-generation obesity drugs being produced in ... the drug lost up to 13.8 kilograms over 48 weeks of ...

Riyadh – The capital city Riyadh hosted the launch of the “SAHEM” program, a distinguished national initiative aimed at ...

Introduction Obesity treatment guidelines suggest moderate-intensity continuous training (MICT), but the patient’s compliance to this indication remains low. High-intensity interval training (HIIT) is ...

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare ...

Policymakers must prioritize access to innovative obesity care in tackling the obesity epidemic across the United States.

The increasing prevalence of overweight and obesity in China poses an urgent public health challenge requiring immediate ...

Ihuoma Eneli, MD, MS, discusses early intervention in childhood obesity to reduce long‑term risk and supporting families with ...

A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says ...

A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...